Corporate Governance

China's new National Security Law makes it clear that national security review is a priority, but the widened scope and vague language used for the types of inbound transactions subject to the process may create additional uncertainty for foreign investors

China's new National Security Law makes it clear that national security review is a priority, but the widened scope and vague language used for the types of inbound transactions subject to the process may create additional uncertainty for foreign investors

Foreign investors allowed access to bank card settlement business.

Chinese and foreign law firms allowed to handle legal matters together in the form of associations in the Shanghai FTZ.

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on

CSRC prevents backdoor listing from circumventing regulation.

The new Foreign Investment Industrial Guidance Catalogue has opened up and closed off a number of key industries accessible to overseas investors. It may be the last version as China moves to further reform the FDI framework

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline